Results 131 to 140 of about 13,841 (201)

Hidden benefits beyond herpes zoster: a potential preventive strategy against hepatobiliary diseases. [PDF]

Korean J Intern Med
Kim DW, Song TJ.
europepmc   +1 more source

Impaired cellular immune responses to herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors. [PDF]

Rheumatology (Oxford)
Källmark H, Gullstrand B, Kahn F, Grenmyr E, Kahn R, Einarsson JT, Bengtsson AA, Kapetanovic MC.   +7 more
europepmc   +1 more source

Claims-based Analysis of Zoster Vaccine Effectiveness against Incident Herpes Zoster: The VENUS Study. [PDF]

JMA J
Murata F, Maeda M, Fukuda H.
europepmc   +1 more source

Varicella-zoster virus reactivation and the risk of dementia. [PDF]

Nat Med
Polisky V, Littmann M, Triastcyn A, Horn M, Georgiou A, Widenmaier R, Anspach B, Tahrat H, Kumar S, Buser-Doepner C, Geldsetzer P, Van Duijn CM, Schwab P.   +12 more
europepmc   +1 more source

Virology [PDF]

, 2004
佐藤 仁志, 吉田 与志博, 景山 誠二, 林 京子, 白木 公康, 黒川 昌彦   +5 more
core   +1 more source

Predictive model of public health impact of herpes zoster vaccination and related costs for adults aged ≥50 years in Republic of Korea. [PDF]

Hum Vaccin Immunother
Min S, Kwon SH, Seo JH, Nam JH, Park JH, Kwon T, Kang HR, Ng C, Lee EK.   +8 more
europepmc   +1 more source

Herpes zoster vaccine uptake following provider prescription among older adults in the United States. [PDF]

J Manag Care Spec Pharm
Carrico J, Zhu Y, Le L, Steffens A, Gallagher S, Stempniewicz N, Gatwood J.   +6 more
europepmc   +1 more source

Cost Effectiveness of Recombinant Zoster Vaccine and Live-Attenuated Vaccine Against Herpes Zoster for Adults Aged 50 and Over in China. [PDF]

Pharmacoecon Open
Liu L, Zhang Q, Shu Y, Wang L, Shuai Z, Chu M, Zhang Z, Zhang R.   +7 more
europepmc   +1 more source

Heterologous Prime-Boost with ChAdOx1-VZV Establishes Dual-Layer Immunogenicity Conferring Protective Potential Against Herpes Zoster. [PDF]

Vaccines (Basel)
Zhao J, Shao J, Sui X, Wei M, Ma X, Xu Z, Zhu T.   +6 more
europepmc   +1 more source

Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine. [PDF]

Ann Intern Med
Vielot NA, Jonsson Funk M, Stürmer T, Fix J, Becker-Dreps S, Weber DJ, Lund JL.   +6 more
europepmc   +1 more source